Tilray Brands' CEO, Irwin Simon, expressed his views on the cannabis industry, stating that US consumers are confused about cannabis regulation. He noted that Tilray does not sell marijuana products in the US due to federal laws, but has expanded its focus to spirits, beer, and food, in addition to its medical marijuana operations in Europe. Simon also expressed hope that the US will learn from Canada's experience with legalizing recreational cannabis. Tilray shares were trading 0.96% lower at $2.06 per share when the market opened on Wednesday.